New Policy Curbs Exaggeration of Heart Transplant Urgency
Prior to a policy change in 1999, heart transplant centers were said to be increasingly exaggerating the severity of their patients’ illnesses […]
World's Largest Resource for Cardiovascular Perfusion
Prior to a policy change in 1999, heart transplant centers were said to be increasingly exaggerating the severity of their patients’ illnesses […]
In conclusion, these authors recommend ECMO use in COVID-19 but with caution and in compliance with current guidelines. While evidence advocating ECMO use in COVID-19 is not substantial, ongoing studies may provide new insight in ECMO use in COVID-19 patients in critical cases. To ensure optimal patient care, a case-by-case approach should be implemented, with risk-benefit analysis conducted for each patient
Late institution of ECMO in lung transplant recipients for causes other than primary graft failure is associated with such poor survival that its use should be considered only in very select cases.